

One Dose That Heals Addiction, PTSD, and Brain Injury? Dr. Nolan Williams on The Science of Ibogaine
56 snips Sep 3, 2025
Dr. Nolan Williams, a pioneering Stanford neuropsychiatrist, discusses the groundbreaking potential of ibogaine for treating addiction, PTSD, and depression. He shares how this unique psychedelic can reset the brain and break addiction cycles. The conversation dives into circuit-based psychiatry, highlighting innovative therapies that shift away from traditional methods. With an eye on safety measures, Dr. Williams emphasizes ibogaine's neuroprotective effects and the promise of personalized medicine, stirring excitement for a new era in mental health treatment.
AI Snips
Chapters
Books
Transcript
Episode notes
Ibogaine’s Broad, Pleiotropic Pharmacology
- Ibogaine is a broad-acting compound that interacts with many neurotransmitter systems rather than a single receptor target.
- This pleiotropic action may explain its strong, multi-domain therapeutic effects compared with single-target drugs.
Life-Review Experience Rewrites Traumatic Memories
- Users report a prolonged introspective 'life review' during ibogaine that recontextualizes emotionally salient memories.
- That reconsolidation-like process appears to reduce trauma-related distress and change memory meaning.
Dopamine Reset Explains Anti‑Addiction Effects
- Ibogaine upregulates glial-derived neurotrophic factor and restores dopamine neuron health in the ventral tegmental area.
- Animal and targeted infusion studies suggest this dopamine reset can stop addictive self-administration behaviors.